查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386257

震盪市场报告：2030 年趋势、预测与竞争分析

Concussion Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

震盪趋势和预测

预计到 2030 年，全球震盪市场将达到约 97.8 亿美元，2024 年至 2030 年年复合成长率为 3.9%。这个市场的主要驱动因素是运动和道路事故造成的伤害数量不断增加、人口高龄化加剧以及全球研发活动的增加。全球脑震盪市场前景广阔，医院/诊所市场和诊断中心市场蕴藏商机。

震盪市场洞察

Lucintel 预测，由于全球脑损伤病例数量不断增加，诊断预计将在预测期内实现高速成长。

由于先进的医疗设备、有利的报销计划以及越来越多的人更喜欢医院作为治疗方法，医院和诊所将继续成为市场的最大部分。

由于脑损伤引起的脑震盪发生率上升以及政府机构和私人公司提高意识的努力，预计北美地区在预测期内将经历最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 未来哪个细分市场成长较快？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球震盪市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球震盪市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球震盪市场
    • 诊断
    • 治疗
  • 以最终用途分類的全球震盪市场
    • 医院和诊所
    • 诊断中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球震盪市场按地区划分
  • 北美震盪市场
  • 欧洲震盪市场
  • 亚太震盪市场
  • 其他区域震盪市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球震盪市场成长机会
    • 按最终用途分類的全球震盪市场成长机会
    • 按地区分類的全球震盪市场成长机会
  • 全球震盪市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球震盪市场的产能
    • 全球震盪市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Zydus Cadila
  • Novartis
  • Lupin
  • Mylan
  • Medtronic
  • Pfizer
  • Sanofi
  • InfraScan
  • Oculogica
  • Raumedic
简介目录

Concussion Trends and Forecast

The future of the global concussion market looks promising with opportunities in the hospital & clinic and diagnostic center markets. The global concussion market is expected to reach an estimated $9.78 billion by 2030 with a CAGR of 3.9% from 2024 to 2030. The major drivers for this market are rising number of injuries from sports and road accidents, increasing aging population, and growing research and development activities across the globe.

A more than 150-page report is developed to help in your business decisions.

Concussion by Segment

The study includes a forecast for the global concussion by type, end use, and region.

Concussion Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnosis
  • Treatment

Concussion Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

Concussion Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Concussion Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies concussion companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the concussion companies profiled in this report include-

  • Zydus Cadila
  • Novartis
  • Lupin
  • Mylan
  • Medtronic
  • Pfizer
  • Sanofi
  • Infrascan
  • Oculogica
  • Raumedic
  • BioDirection

Concussion Market Insights

Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing number of brain injury cases across the globe.

Within this market, hospitals & clinics will remain the largest segment due to avialability of advanced medical equipment and favorable reimbursement facilities and increasing preference of people towards hospitals as a preffered mode of treatment.

North America is expected to witness highest growth over the forecast period due to the rising incidence of concussions stemming from brain injuries along with increasing awareness efforts by government organizations and private firms.

Features of the Global Concussion Market

Market Size Estimates: Concussion market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Concussion Market size by type, end use, and region in terms of value ($B).

Regional Analysis: Concussion market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the concussion market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the concussion market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the concussion market size?

Answer: The global concussion market is expected to reach an estimated $9.78 billion by 2030.

Q.2 What is the growth forecast for concussion market?

Answer: The global concussion market is expected to grow with a CAGR of 3.9% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the concussion market?

Answer: The major drivers for this market are rising number of injuries from sports and road accidents, increasing aging population, and growing research and development activities across the globe.

Q4. What are the major segments for concussion market?

Answer: The future of the concussion market looks promising with opportunities in the hospital & clinic and diagnostic center markets.

Q5. Who are the key Concussion Market companies?

Answer: Some of the key concussion companies are as follows:

  • Zydus Cadila
  • Novartis
  • Lupin
  • Mylan
  • Medtronic
  • Pfizer
  • Sanofi
  • InfraScan
  • Oculogica
  • Raumedic

Q6. Which concussion market segment will be the largest in future?

Answer: Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing number of brain injury cases across the globe.

Q7. In concussion market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the rising incidence of concussions stemming from brain injuries along with increasing awareness efforts by government organizations and private firms.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the concussion market by type (diagnosis and treatment), end use (hospitals and clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Concussion Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Concussion Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Concussion Market by Type
    • 3.3.1: Diagnosis
    • 3.3.2: Treatment
  • 3.4: Global Concussion Market by End Use
    • 3.4.1: Hospitals & Clinics
    • 3.4.2: Diagnostic Centers
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Concussion Market by Region
  • 4.2: North American Concussion Market
    • 4.2.2: North American Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
  • 4.3: European Concussion Market
    • 4.3.1: European Concussion Market by Type: Diagnosis and Treatment
    • 4.3.2: European Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
  • 4.4: APAC Concussion Market
    • 4.4.1: APAC Concussion Market by Type: Diagnosis and Treatment
    • 4.4.2: APAC Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
  • 4.5: ROW Concussion Market
    • 4.5.1: ROW Concussion Market by Type: Diagnosis and Treatment
    • 4.5.2: ROW Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Concussion Market by Type
    • 6.1.2: Growth Opportunities for the Global Concussion Market by End Use
    • 6.1.3: Growth Opportunities for the Global Concussion Market by Region
  • 6.2: Emerging Trends in the Global Concussion Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Concussion Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Concussion Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Zydus Cadila
  • 7.2: Novartis
  • 7.3: Lupin
  • 7.4: Mylan
  • 7.5: Medtronic
  • 7.6: Pfizer
  • 7.7: Sanofi
  • 7.8: InfraScan
  • 7.9: Oculogica
  • 7.10: Raumedic